Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 1
1950 1
1951 2
1952 4
1959 3
1960 1
1961 1
1964 4
1965 1
1966 2
1967 1
1968 7
1969 6
1970 6
1971 8
1972 1
1973 4
1974 8
1975 3
1977 5
1978 4
1979 3
1980 1
1981 3
1982 3
1983 1
1984 1
1985 5
1986 3
1987 2
1988 1
1989 4
1990 2
1991 2
1992 3
1993 4
1994 2
1995 3
1996 3
1997 1
1998 4
1999 12
2000 6
2001 5
2002 5
2003 4
2004 6
2005 10
2006 10
2007 14
2008 14
2009 11
2010 13
2011 20
2012 13
2013 19
2014 31
2015 20
2016 13
2017 21
2018 16
2019 20
2020 20
2021 13
2022 10
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

421 results

Results by year

Filters applied: . Clear all
Page 1
GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells.
Smith EL, Harrington K, Staehr M, Masakayan R, Jones J, Long TJ, Ng KY, Ghoddusi M, Purdon TJ, Wang X, Do T, Pham MT, Brown JM, De Larrea CF, Olson E, Peguero E, Wang P, Liu H, Xu Y, Garrett-Thomson SC, Almo SC, Wendel HG, Riviere I, Liu C, Sather B, Brentjens RJ. Smith EL, et al. Among authors: wendel hg. Sci Transl Med. 2019 Mar 27;11(485):eaau7746. doi: 10.1126/scitranslmed.aau7746. Sci Transl Med. 2019. PMID: 30918115 Free PMC article.
The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase.
Sanghvi VR, Leibold J, Mina M, Mohan P, Berishaj M, Li Z, Miele MM, Lailler N, Zhao C, de Stanchina E, Viale A, Akkari L, Lowe SW, Ciriello G, Hendrickson RC, Wendel HG. Sanghvi VR, et al. Among authors: wendel hg. Cell. 2019 Aug 8;178(4):807-819.e21. doi: 10.1016/j.cell.2019.07.031. Cell. 2019. PMID: 31398338 Free PMC article.
Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape-Driven Relapse in Multiple Myeloma.
Fernández de Larrea C, Staehr M, Lopez AV, Ng KY, Chen Y, Godfrey WD, Purdon TJ, Ponomarev V, Wendel HG, Brentjens RJ, Smith EL. Fernández de Larrea C, et al. Among authors: wendel hg. Blood Cancer Discov. 2020 Sep;1(2):146-154. doi: 10.1158/2643-3230.BCD-20-0020. Blood Cancer Discov. 2020. PMID: 33089218 Free PMC article.
Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia.
Santomasso BD, Park JH, Salloum D, Riviere I, Flynn J, Mead E, Halton E, Wang X, Senechal B, Purdon T, Cross JR, Liu H, Vachha B, Chen X, DeAngelis LM, Li D, Bernal Y, Gonen M, Wendel HG, Sadelain M, Brentjens RJ. Santomasso BD, et al. Among authors: wendel hg. Cancer Discov. 2018 Aug;8(8):958-971. doi: 10.1158/2159-8290.CD-17-1319. Epub 2018 Jun 7. Cancer Discov. 2018. PMID: 29880584 Free PMC article. Clinical Trial.
The cat-and-mouse game of BTK inhibition.
Portelinha A, Wendel HG. Portelinha A, et al. Among authors: wendel hg. Blood. 2023 Mar 30;141(13):1502-1503. doi: 10.1182/blood.2022018936. Blood. 2023. PMID: 36995705 Free article. No abstract available.
Emerging epigenetic-modulating therapies in lymphoma.
Sermer D, Pasqualucci L, Wendel HG, Melnick A, Younes A. Sermer D, et al. Among authors: wendel hg. Nat Rev Clin Oncol. 2019 Aug;16(8):494-507. doi: 10.1038/s41571-019-0190-8. Nat Rev Clin Oncol. 2019. PMID: 30837715 Free PMC article. Review.
Toward a Long-Term Artificial Lung.
Arens J, Grottke O, Haverich A, Maier LS, Schmitz-Rode T, Steinseifer U, Wendel HP, Rossaint R. Arens J, et al. Among authors: wendel hp. ASAIO J. 2020 Aug;66(8):847-854. doi: 10.1097/MAT.0000000000001139. ASAIO J. 2020. PMID: 32740342 Free PMC article. Review.
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing.
Parsa S, Ortega-Molina A, Ying HY, Jiang M, Teater M, Wang J, Zhao C, Reznik E, Pasion JP, Kuo D, Mohan P, Wang S, Camarillo JM, Thomas PM, Jain N, Garcia-Bermudez J, Cho BK, Tam W, Kelleher NL, Socci N, Dogan A, De Stanchina E, Ciriello G, Green MR, Li S, Birsoy K, Melnick AM, Wendel HG. Parsa S, et al. Among authors: wendel hg. Nat Cancer. 2020;1:653-664. doi: 10.1038/s43018-020-0080-0. Epub 2020 Jun 22. Nat Cancer. 2020. PMID: 33569544 Free PMC article.
Progress against follicular lymphoma.
Schatz JH, Oricchio E, Puvvada SD, Wendel HG. Schatz JH, et al. Among authors: wendel hg. Curr Opin Hematol. 2013 Jul;20(4):320-6. doi: 10.1097/MOH.0b013e3283622ed6. Curr Opin Hematol. 2013. PMID: 23673338 Free PMC article. Review.
421 results